FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736740976> ?p ?o ?g. }

• W2736740976 abstract "We assessed the feasibility of field-based directly observed therapy (DOT) with minimal monitoring to deliver HCV treatment to people with a history of drug use in Chennai, India. Fifty participants were randomized 1:1 to sofosbuvir+peginterferon alfa 2a+ribavirin (SOF+PR) for 12 weeks (Arm 1) vs sofosbuvir+ribavirin (SOF+R) for 24 weeks (Arm 2). SOF+R was delivered daily at participant chosen venues and weekly peginterferon injections at the study clinic. HCV RNA testing was performed to confirm active HCV infection and sustained virologic response 12 weeks after treatment completion (SVR12). No baseline genotyping or on-treatment viral loads were performed. Median age was 46 years. All were male and 20% had significant fibrosis/cirrhosis. All self-reported history of injection drug use, 18% recent noninjection drug use and 38% alcohol dependence. Six discontinued treatment (88% completed treatment in each arm). Of 22 who completed SOF+PR, all achieved SVR12 (22/25=88%); 15 of 22 who completed SOF+R achieved SVR12 (15/25=60%; P=.05). Among those completing SOF+R, SVR12 was significantly less common in participants reporting ongoing substance use (36% vs 100%) and missed doses. Active substance use and missed doses did not impact SVR with SOF+PR. Field-based DOT of HCV therapy without real-time HCV RNA monitoring was feasible; however, achieving 100% adherence was challenging. SOF+PR appeared superior to SOF+R in achieving SVR12, even when doses were missed with no discontinuations due to side effects. Further exploration of short duration treatment with peginterferon plus direct-acting antivirals is warranted." @default.
• W2736740976 created "2017-07-31" @default.
• W2736740976 creator A5001429601 @default.
• W2736740976 creator A5012160948 @default.
• W2736740976 creator A5013317411 @default.
• W2736740976 creator A5015990889 @default.
• W2736740976 creator A5042693689 @default.
• W2736740976 creator A5045447716 @default.
• W2736740976 creator A5046461979 @default.
• W2736740976 creator A5054201295 @default.
• W2736740976 creator A5068863088 @default.
• W2736740976 creator A5087051778 @default.
• W2736740976 date "2017-08-14" @default.
• W2736740976 modified "2023-10-17" @default.
• W2736740976 title "Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)" @default.
• W2736740976 cites W1844871208 @default.
• W2736740976 cites W1949789545 @default.
• W2736740976 cites W1973760746 @default.
• W2736740976 cites W1975933189 @default.
• W2736740976 cites W1980771473 @default.
• W2736740976 cites W2007812574 @default.
• W2736740976 cites W2009468511 @default.
• W2736740976 cites W2019312361 @default.
• W2736740976 cites W2029697563 @default.
• W2736740976 cites W2034703556 @default.
• W2736740976 cites W2035745042 @default.
• W2736740976 cites W2061218069 @default.
• W2736740976 cites W2081897332 @default.
• W2736740976 cites W2085981430 @default.
• W2736740976 cites W2089465091 @default.
• W2736740976 cites W2092646281 @default.
• W2736740976 cites W2119510460 @default.
• W2736740976 cites W2127548135 @default.
• W2736740976 cites W2131064431 @default.
• W2736740976 cites W2141769755 @default.
• W2736740976 cites W2148840656 @default.
• W2736740976 cites W2150652264 @default.
• W2736740976 cites W2151554611 @default.
• W2736740976 cites W2161844941 @default.
• W2736740976 cites W2261526891 @default.
• W2736740976 cites W2278700271 @default.
• W2736740976 cites W2301185065 @default.
• W2736740976 cites W2410859412 @default.
• W2736740976 cites W2420900831 @default.
• W2736740976 cites W2462910389 @default.
• W2736740976 cites W2508191793 @default.
• W2736740976 cites W2516395986 @default.
• W2736740976 cites W2520046479 @default.
• W2736740976 cites W2546099614 @default.
• W2736740976 cites W2556159858 @default.
• W2736740976 cites W2560338714 @default.
• W2736740976 cites W2578013986 @default.
• W2736740976 cites W2594124626 @default.
• W2736740976 cites W2620978509 @default.
• W2736740976 cites W4301258562 @default.
• W2736740976 doi "https://doi.org/10.1111/jvh.12761" @default.
• W2736740976 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5743582" @default.
• W2736740976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28719029" @default.
• W2736740976 hasPublicationYear "2017" @default.
• W2736740976 type Work @default.
• W2736740976 sameAs 2736740976 @default.
• W2736740976 citedByCount "4" @default.
• W2736740976 countsByYear W27367409762017 @default.
• W2736740976 countsByYear W27367409762018 @default.
• W2736740976 countsByYear W27367409762019 @default.
• W2736740976 crossrefType "journal-article" @default.
• W2736740976 hasAuthorship W2736740976A5001429601 @default.
• W2736740976 hasAuthorship W2736740976A5012160948 @default.
• W2736740976 hasAuthorship W2736740976A5013317411 @default.
• W2736740976 hasAuthorship W2736740976A5015990889 @default.
• W2736740976 hasAuthorship W2736740976A5042693689 @default.
• W2736740976 hasAuthorship W2736740976A5045447716 @default.
• W2736740976 hasAuthorship W2736740976A5046461979 @default.
• W2736740976 hasAuthorship W2736740976A5054201295 @default.
• W2736740976 hasAuthorship W2736740976A5068863088 @default.
• W2736740976 hasAuthorship W2736740976A5087051778 @default.
• W2736740976 hasBestOaLocation W27367409762 @default.
• W2736740976 hasConcept C126322002 @default.
• W2736740976 hasConcept C142462285 @default.
• W2736740976 hasConcept C159047783 @default.
• W2736740976 hasConcept C197934379 @default.
• W2736740976 hasConcept C2522874641 @default.
• W2736740976 hasConcept C2776408679 @default.
• W2736740976 hasConcept C2776455275 @default.
• W2736740976 hasConcept C2778390639 @default.
• W2736740976 hasConcept C2780035454 @default.
• W2736740976 hasConcept C2780040827 @default.
• W2736740976 hasConcept C3013748606 @default.
• W2736740976 hasConcept C71924100 @default.
• W2736740976 hasConcept C98274493 @default.
• W2736740976 hasConceptScore W2736740976C126322002 @default.
• W2736740976 hasConceptScore W2736740976C142462285 @default.
• W2736740976 hasConceptScore W2736740976C159047783 @default.
• W2736740976 hasConceptScore W2736740976C197934379 @default.
• W2736740976 hasConceptScore W2736740976C2522874641 @default.
• W2736740976 hasConceptScore W2736740976C2776408679 @default.
• W2736740976 hasConceptScore W2736740976C2776455275 @default.
• W2736740976 hasConceptScore W2736740976C2778390639 @default.
• W2736740976 hasConceptScore W2736740976C2780035454 @default.
• W2736740976 hasConceptScore W2736740976C2780040827 @default.

• next